Correlation Between Sarepta Therapeutics and Propanc Biopharma
Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and Propanc Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and Propanc Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sarepta Therapeutics and Propanc Biopharma, you can compare the effects of market volatilities on Sarepta Therapeutics and Propanc Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of Propanc Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and Propanc Biopharma.
Diversification Opportunities for Sarepta Therapeutics and Propanc Biopharma
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Sarepta and Propanc is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and Propanc Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Propanc Biopharma and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with Propanc Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Propanc Biopharma has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and Propanc Biopharma go up and down completely randomly.
Pair Corralation between Sarepta Therapeutics and Propanc Biopharma
Given the investment horizon of 90 days Sarepta Therapeutics is expected to generate 0.1 times more return on investment than Propanc Biopharma. However, Sarepta Therapeutics is 10.33 times less risky than Propanc Biopharma. It trades about -0.09 of its potential returns per unit of risk. Propanc Biopharma is currently generating about -0.02 per unit of risk. If you would invest 13,750 in Sarepta Therapeutics on February 28, 2024 and sell it today you would lose (1,404) from holding Sarepta Therapeutics or give up 10.21% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Sarepta Therapeutics vs. Propanc Biopharma
Performance |
Timeline |
Sarepta Therapeutics |
Propanc Biopharma |
Sarepta Therapeutics and Propanc Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sarepta Therapeutics and Propanc Biopharma
The main advantage of trading using opposite Sarepta Therapeutics and Propanc Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, Propanc Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Propanc Biopharma will offset losses from the drop in Propanc Biopharma's long position.Sarepta Therapeutics vs. MicroAlgo | Sarepta Therapeutics vs. Morningstar Unconstrained Allocation | Sarepta Therapeutics vs. T Rowe Price | Sarepta Therapeutics vs. Nt International Small Mid |
Propanc Biopharma vs. Greater Cannabis | Propanc Biopharma vs. GelStat Corp | Propanc Biopharma vs. Pure Harvest Cannabis | Propanc Biopharma vs. Ionic Brands Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |